Status:
COMPLETED
Randomized Trial to Assess the Impact of a Screening Program on Upper Aerodigestive Tract Cancer Mortality in a High Risk Population
Lead Sponsor:
Gustave Roussy, Cancer Campus, Grand Paris
Conditions:
Pharynx Cancer
Larynx Cancer
Eligibility:
All Genders
40+ years
Phase:
PHASE3
Brief Summary
Randomized multicenter trial to assess the impact of a screening program for heavy alcohol drinkers and smokers treated in alcohol addiction clinics on upper aerodigestive tract cancer mortality.
Detailed Description
Upper aerodigestive tract (UADT) carcinomas (oral cavity and pharynx (63%), larynx (17%) and esophagus (20%)), are frequent in France with 25.000 new cases annually estimated in 2000, representing 13%...
Eligibility Criteria
Inclusion
- current or previous heavy smokers (smoked \>= 20 years) and alcohol drinkers who need specialized care
Exclusion
- Head and neck clinical examination during the past 6 months
- History of squamous cell carcinoma of the upper aero-digestive tract.
- Recent digestive hemorrhage from varicose esophagus
Key Trial Info
Start Date :
June 21 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 18 2015
Estimated Enrollment :
1993 Patients enrolled
Trial Details
Trial ID
NCT00359645
Start Date
June 21 2006
End Date
December 18 2015
Last Update
May 16 2017
Active Locations (35)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier MONTPERRIN
Aix-en-Provence, France, 13100
2
CHIAB Annemasse Bonneville
Annemasse, France, 74 100
3
Centre Hospitalier d'ARRAS
Arras, France, 62000
4
CHS de L'Yonne
Auxerre, France, 89000